Publications by authors named "Ghayas Issa"

Claim this Profile
O
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase.
Omer Karrar, Hagop Kantarjian, Fadi G Haddad, Roberta S Azevedo, Ghayas Issa

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and relapse dynamics in AML after three years of complete remission.
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, Peter H Wiernik, Tapan Kadia, Ghayas Issa

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemia.
Wei-Ying Jen, Guilin Tang, Eitan Kugler, Jennifer Croden, Koji Sasaki, Ghayas C Issa

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.
Hannah Goulart, Farhad Ravandi, Nicholas J Short, Nitin Jain, Naval Daver, Ghayas C Issa, Issa Khouri

JCO Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.
Courtney D DiNardo, Wei-Ying Jen, Koichi Takahashi, Tapan M Kadia, Sanam Loghavi, Ghayas C Issa

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial.
Jorge E Cortes, Timothy P Hughes, Jianxiang Wang, Dong-Wook Kim, Dennis Dong Hwan Kim, Ghayas C Issa

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy-Based Regimens.
Hannah Goulart, Elias Jabbour, Nicholas Short, Nitin Jain, Ghayas Issa

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies.
Wei-Ying Jen, Sanam Loghavi, Alexandre Bazinet, Alex Bataller, Ian Bouligny, Ghayas C Issa

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomolecular Mechanisms of Relapse and Post-Relapse Outcomes After Frontline FLT3 Inhibitor-Based Therapy in FLT3 -Mutated AML.
Sankalp Arora, Sanam Loghavi, Naval Daver, Farhad Ravandi, Courtney D DiNardo, Ghayas C Issa

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Strategies with Menin Inhibitors for Acute Leukemia.
Ghayas C Issa, Sheng F Cai, Alex Bataller, Hagop M Kantarjian, Eytan M Stein

Blood Cancer Discov· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML.
Reeja Raj, Samanta Catueno, Amber Gibson, David McCall, Miriam B Garcia, Ghayas C Issa

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1.
Courtney D DiNardo, Wei-Ying Jen, Guillermo Montalban-Bravo, Xuemei Wang, Sanam Loghavi, Ghayas C Issa

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziftomenib in Relapsed or Refractory -Mutated AML.
Eunice S Wang, Pau Montesinos, James Foran, Harry Erba, Eduardo Rodríguez-Arbolí, Ghayas C Issa

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens.
Hagop M Kantarjian, Gautam Borthakur, Naval Daver, Courtney DiNardo, Guillermo Garcia-Manero, Ghayas Issa

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy.
Sven Turkalj, Felix A Radtke, Bilyana Stoilova, Rabea Mecklenbrauck, Angus J Groom, Ghayas C Issa

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia with t(10;17)(p15;q21)/: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults.
Qing Wei, Naveen Pemmaraju, Sa A Wang, Shimin Hu, Courtney DiNardo, Ghayas C Issa

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide.
Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, Jessica K Altman, Musa Yilmaz, Ghayas C Issa

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias.
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, Elias Jabbour, Tapan Kadia

J Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax.
Jennifer Croden, Wei-Ying Jen, Jennifer Marvin-Peek, Lianchun Xiao, Ian M Bouligny, Ghayas C Issa

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor.
Nicholas J Short, Sanam Loghavi, Musa Yilmaz, Omer Karrar, Kunhwa Kim, Ghayas C Issa

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD123 expression and its correlation with mutation profile in acute myeloid leukaemia.
Roberta S Azevedo, Sa A Wang, David M Swanson, Naval G Daver, Naveen Pemmaraju, Ghayas C Issa

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy.
Alexandre Bazinet, Sanam Loghavi, Yue Wei, Alex Bataller, Koji Sasaki, Ghayas Issa

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia.
Jayastu Senapati, Hagop M Kantarjian, Tapan M Kadia, Jeannot Kekedjian, Gautam Borthakur, Ghayas C Issa

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation.
Sankalp Arora, Wei-Ying Jen, Musa Yilmaz, Indraneel Deshmukh, Jayastu Senapati, Ghayas C Issa

Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Chronic Myeloid Leukemia During Pregnancy: Review of Evidence and Treatment Algorithm.
Fadi G Haddad, Jennifer Croden, Koji Sasaki, Ghayas C Issa, Naveen Pemmaraju

Clin Lymphoma Myeloma Leuk· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis